Medical Weight Loss for Spokane, Washington Residents

Spokane, Washington residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Spokane through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Washington, including Spokane: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Spokane Residents Choose New Hope Weight Loss

Some patients in Spokane are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.

Spokane and the Inland Northwest are served through telehealth from our Costa Mesa, California clinic, closing a real specialty-access gap for the region with the same care offered nationwide.

If you are searching for a weight-loss physician in Spokane, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts Washington patients exactly where local ones are. We care for patients throughout Downtown, the South Hill, Kendall Yards, the North Side, and the greater Inland Northwest. Your semaglutide or tirzepatide travels in insulated cold-pack packaging to keep it stable on the way to Spokane, even on warm Washington afternoons.

Distance simply stops mattering here, since every appointment for Spokane residents takes place over secure video rather than in a waiting room. Cold-pack shipping to Spokane is handled for you, and refills are coordinated through telehealth so you do not have to manage a pharmacy pickup. From the Puget Sound cities to the eastern plains of Washington, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Spokane meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Spokane

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Spokane address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Spokane

Where is the New Hope Weight Loss location serving Spokane?

The location serving Spokane is our Costa Mesa, California clinic, which is our only physical site. We care for Spokane, Washington patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Spokane patients?

It is the standard for Spokane. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Spokane in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Spokane patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Spokane patients.

What areas of Spokane do you serve?

We serve patients from across Spokane by telehealth, including Downtown, the South Hill, Kendall Yards, the North Side, and the greater Inland Northwest.

How does telehealth help Spokane patients with specialty access?

Telehealth gives Spokane patients access to a named, licensed physician, real contraindication screening, and a transparent 503(a) compounding pharmacy, without depending on what is locally available. The consultation and follow-up happen by secure video.

Spokane Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Spokane, Washington by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.